News | January 06, 2026
Abbott unveils Libre Assist to help meal management in diabetics
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
MANEUVER met all five key secondary endpoints, with statistically significant and clinically meaningful improvements in pain, stiffness, range of motion, physical function, and decrease in tumor volume
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
First and only PARP inhibitor to improve overall survival in early breast cancer
Subscribe To Our Newsletter & Stay Updated
